Position in MRK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,154,289
+$176,150 QoQ
Shares Held
24,547
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#1,311
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argent Advisors, Inc. holds $22,940,677 across 9 Drug Manufacturers - General names. MRK ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,391 | $5,266,697 | |
| 2 | JNJ |
Johnson & Johnson
|
20,074 | $5,098,193 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
24,547 | $3,154,289 | |
| 4 | GSK |
GSK plc
|
51,943 | $2,722,852 | |
| 5 | PFE |
Pfizer Inc
|
109,643 | $2,640,203 | |
| 6 | AMGN |
Amgen Inc
|
4,586 | $1,660,682 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,701 | $1,478,304 | |
| 8 | ABBV |
AbbVie Inc.
|
2,592 | $652,250 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,154,289 | 24,547 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,978,139 | 24,758 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,612,553 | 24,820 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,045,374 | 24,370 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,819,334 | 22,983 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,849,325 | 20,603 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,648,781 | 16,574 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,841,148 | 16,213 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,056,689 | 16,613 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,188,786 | 16,588 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,819,325 | 16,688 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,735,428 | 16,857 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,952,514 | 16,921 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,824,801 | 17,152 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,016,072 | 18,171 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,599,851 | 18,577 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,713,904 | 18,799 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,545,986 | 18,842 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,342,579 | 17,518 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,304,059 | 17,362 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,189,025 | 15,289 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,098,456 | 14,249 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $1,103,890 | 13,495 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,001,289 | 12,071 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $905,612 | 11,711 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $825,181 | 10,725 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||